DRUG RETENTION OF BIOLOGIC AND TARGETED SYNTHETIC DMARDS IN KOREAN SEROPOSITIVE RHEUMATOID ARTHRITIS (RA) PATIENTS: A REALWORLD SINGLE-CENTER RETROSPECTIVE STUDY

被引：0
|
作者：
Lee, B. W. [1 ]
Lee, J. J. [1 ]
Kim, W. U. [1 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; Targeted synthetic drugs; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.3677
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0854
引用
收藏
页码：730 / 731
页数：2
相关论文
共 50 条
  • [31] Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?
    Ozsoy, Zehra
    Ozdemir, Adem
    Ekici, Mustafa
    Bilgin, Emre
    Kilic, Levent
    Kiraz, Sedat
    Saribas, Zeynep
    Sener, Burcin
    Karadag, Omer
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (08) : 1445 - 1451
  • [32] Ultrasound Evaluation of the Efficacy of Biologic and Targeted Synthetic Dmards Toward Rheumatoid Arthritis Patients: Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort in Japan
    Nishino, Ayako
    Kawashiri, Shin-ya
    Kawakami, Atsushi
    Yoshitama, Tamami
    Eiraku, Nobutaka
    Matsuoka, Noki
    Ueki, Yukitaka
    Okada, Akitomo
    Hamada, Hiroaki
    Hidaka, Toshihiko
    Nagano, Shuji
    Tsuru, Tomomi
    Fujikawa, Keita
    Arinobu, Yojiro
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] Reasons and Predictors of Treatment Change in Rheumatoid Arthritis Patients Treated with Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Single-Center Retrospective Observational Study
    Nakagawa, Chihiro
    Ota, Ryosuke
    Hirata, Atsushi
    Yokoyama, Satoshi
    Uno, Takaya
    Hosomi, Kouichi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (10) : 1759 - 1767
  • [34] EFFECT OF BODY MASS INDEX ON TREATMENT RESPONSE OF BIOLOGIC-/TARGETED SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS
    Gialouri, C. G.
    Pappa, M.
    Evangelatos, G.
    Nikiphorou, E.
    Fragoulis, G. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1698 - 1698
  • [35] Reasons for Early Discontinuation of Targeted Synthetic (ts) or Biologic (b) DMARDs; Chart Review of 20,343 Drug Episodes Given to Patients with Rheumatoid Arthritis
    Huston, Kent Kwas
    Adams, Christopher
    Helfgott, Simon
    Singh, Jasvinder
    Soloman, Nehad
    Persons, Dan
    Milligan, Scott
    Edgerton, Colin
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 498 - 501
  • [36] PREVALENCE OF OSTEOPOROSIS AMONG RHEUMATOID ARTHRITIS PATIENTS IN TAIWAN: A SINGLE-CENTER RETROSPECTIVE STUDY IN SOUTHERN TAIWAN
    Ng, K. J.
    Lu, M-C
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 24 - 24
  • [37] Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study
    Morsley K.
    Kilner T.
    Steuer A.
    Rheumatology and Therapy, 2015, 2 (2) : 165 - 172
  • [38] Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study
    Yeo-Jin Song
    Soo-Kyung Cho
    Hyoungyoung Kim
    Hye Won Kim
    Eunwoo Nam
    Ja-Young Jeon
    Hyun-Jeong Yoo
    Chan-Bum Choi
    Tae-Hwan Kim
    Jae-Bum Jun
    Sang-Cheol Bae
    Dae Hyun Yoo
    Yoon-Kyoung Sung
    Scientific Reports, 13
  • [39] Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study
    Song, Yeo-Jin
    Cho, Soo-Kyung
    Kim, Hyoungyoung
    Kim, Hye Won
    Nam, Eunwoo
    Jeon, Ja-Young
    Yoo, Hyun-Jeong
    Choi, Chan-Bum
    Kim, Tae-Hwan
    Jun, Jae-Bum
    Bae, Sang-Cheol
    Yoo, Dae Hyun
    Sung, Yoon-Kyoung
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [40] Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review
    Schlager, Lukas
    Loiskandl, Michaela
    Aletaha, Daniel
    Radner, Helga
    RHEUMATOLOGY, 2020, 59 (02) : 324 - 334
12345